NCT02217384

Brief Summary

Background. Anorexia nervosa (AN) still carries the highest fatality rate of any psychiatric disease, and less than half of the patients recover, completely refractory to any treatment. The etiology remains unknown and evidence for treatment is lacking. The intestinal microbiota and its microbiome provide humans with additional gene products which may be regarded as an organ, which contributes to multiple host metabolic pathways. Recent advances in microbial DNA sequencing technologies have resulted in metagenomic DNA analysis of whole ecosystems such as the human gut. Altered intestinal microbiota has been related to obesity and insulin resistance. Hypothetically, the intestinal microbiota could play a role in the generation and/or maintenance of the emaciation in AN. Aim. The aim of the present study is to investigate whether gut microbiota is altered in patients with AN. Subjects and methods. A cross sectional study of the gut microbiome profiles in 75 clinical, psychometric and biochemical well characterized treatment seeking females with AN. The microbiome profiles are compared with 75 age- matched healthy Danish control subjects. Perspectives. Clarifying whether the intestinal flora is implicated in the susceptibility to or maintenance of AN may provide the basis for development of new highly required treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2014

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2014

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 15, 2014

Completed
17 days until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
6.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

2 years

First QC Date

July 29, 2014

Last Update Submit

February 4, 2024

Conditions

Keywords

MicrobiomeDNA sequencingLeptinAdiponectinInsulinIGF-I

Outcome Measures

Primary Outcomes (1)

  • Diversity of faecal microbiota

    Metagenomic analyses of microbial DNA isolated from stool samples and sequenced applying a combination of deep and untargeted shotgun sequencing.

    Cross-sectional study with only one time point. The sample is delivered at a convenient time during an ongoing psychotherapeutic treatment.

Eligibility Criteria

Age15 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients referred to specialist unit.

You may qualify if:

  • Women.
  • Referred to specialized eating disorder center.
  • Fulfill criteria in Diagnostic and Statistical Manual of Mental Disorders - 5.

You may not qualify if:

  • Age \<15 years.
  • Known ongoing abuse of laxatives.
  • Antibiotic treatment within the last three months.
  • Inflammatory bowel disease, colorectal cancer or other bowel disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Unit for Psychiatric Research, Aalborg University Hospital.

Aalborg, 9000, Denmark

Location

Child and adolescent psychiatric unit. Risskov. Aarhus University Hospital.

Aarhus, 8000, Denmark

Location

Department of Endocrinology, Center for Eating Disorders. Odense University Hospital.

Odense, 5000, Denmark

Location

Biospecimen

Retention: SAMPLES WITH DNA

Gut microbiome Serum and plasma Cells (buffy coat) Urine

MeSH Terms

Conditions

Anorexia NervosaInsulin Resistance

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • René K Støving, PhD

    Center for Eating Disorders, Odense University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research secretary

Study Record Dates

First Submitted

July 29, 2014

First Posted

August 15, 2014

Study Start

September 1, 2014

Primary Completion

September 1, 2016

Study Completion

April 1, 2023

Last Updated

February 6, 2024

Record last verified: 2024-02

Locations